News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Journal of Virology Publication Highlights Antiviral Activity Of AVI BioPharma's (AVII) NEUGENE Antisense Compound



10/19/2005 5:11:28 PM

AVI BioPharma, Inc. (Nasdaq:AVII), today announced publication of positive preclinical data relating to its NEUGENE(R) antisense compound in the June issue of the Journal of Virology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES